John S. Kovach
Net Worth
Last updated:
What is John S. Kovach net worth?
The estimated net worth of Dr. John S. Kovach is at least $611,139 as of 30 Nov 2020. He owns shares worth $73,639 as insider and has received compensation worth at least $537,500 in Lixte Biotechnology Holdings, Inc..
What is the salary of John S. Kovach?
Dr. John S. Kovach salary is $107,500 per year as Founder, Pres, Chief Executive Officer, Chief Scientific Officer & Chairman in Lixte Biotechnology Holdings, Inc..
How old is John S. Kovach?
Dr. John S. Kovach is 88 years old, born in 1937.
What stocks does John S. Kovach currently own?
As insider, Dr. John S. Kovach owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Lixte Biotechnology Holdings, Inc. (LIXT) | Founder, Pres, Chief Executive Officer, Chief Scientific Officer & Chairman | 21,100 | $3.49 | $73,639 |
What does Lixte Biotechnology Holdings, Inc. do?
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures for the treatment of cancers, and vascular and metabolic diseases; and LB-200 series to treat chronic hereditary diseases, such as Gaucher's disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group, as well as Netherlands Cancer Institute and Oncode Institute. The company was founded in 2005 and is based in Pasadena, California.
John S. Kovach insider trading
Lixte Biotechnology Holdings key executives
Lixte Biotechnology Holdings, Inc. executives and other stock owners filed with the SEC:
- Dr. James S. Miser M.D. (77) Chief Medical Officer
- Dr. John S. Kovach (88) Founder, Pres, Chief Executive Officer, Chief Scientific Officer & Chairman
- Mr. Eric J. Forman J.D. (45) Chief Admin. Officer
- Mr. Robert Neal Weingarten (73) Vice President & Chief Financial Officer